scanX
Home
IPCA Laboratories

IPCA Laboratories

1,568.00
-6.50
(-0.41%)
Market Cap (₹ Cr.)
₹39,910
52 Week High
1,708.65
Book Value
₹250
52 Week Low
1,041.00
PE Ratio
59.43
PB Ratio
5.96
PE for Sector
37.21
PB for Sector
3.95
ROE
6.85 %
ROCE
11.22 %
Dividend Yield
0.25 %
EPS
₹23.14
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
22.92 %
Net Income Growth
7.58 %
Cash Flow Change
17.23 %
ROE
-17.64 %
ROCE
-23.35 %
EBITDA Margin (Avg.)
11.78 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
664
762
752
691
640
860
891
756
673
719
875
870
794
868
1,012
960
848
1,030
1,227
1,157
1,018
1,497
1,313
1,331
1,061
1,492
1,439
1,342
1,190
1,496
1,530
1,464
1,435
1,530
1,699
1,524
1,526
1,581
1,828
Expenses
594
687
686
597
573
735
749
644
598
691
715
698
673
740
825
716
659
816
951
874
812
897
938
966
824
1,085
1,065
1,017
996
1,223
1,224
1,229
1,226
1,189
1,354
1,234
1,313
1,213
1,409
EBITDA
71
75
66
94
67
125
141
112
74
28
160
172
121
128
187
244
189
214
276
283
206
600
375
364
237
408
374
325
194
273
306
235
209
341
345
290
213
369
419
Operating Profit %
5 %
8 %
7 %
11 %
9 %
14 %
15 %
14 %
11 %
3 %
17 %
19 %
14 %
13 %
17 %
24 %
21 %
19 %
22 %
23 %
19 %
40 %
28 %
27 %
21 %
27 %
25 %
23 %
15 %
17 %
18 %
15 %
13 %
20 %
19 %
18 %
13 %
23 %
22 %
Depreciation
44
40
37
40
44
42
43
43
43
43
44
44
43
44
43
43
42
42
45
46
45
45
46
48
49
50
51
51
54
55
56
58
59
60
61
63
62
61
63
Interest
8
6
7
9
7
6
6
5
6
6
6
6
6
5
2
5
6
4
4
4
3
2
2
2
2
1
1
1
3
7
9
10
18
31
39
27
24
19
17
Profit Before Tax
18
29
22
45
16
77
92
64
26
-21
110
123
72
78
141
197
141
168
227
233
157
552
327
315
186
356
322
272
137
211
240
167
132
250
245
200
127
288
339
Tax
0
6
5
10
1
16
21
14
5
0
19
26
14
16
26
42
31
37
33
41
28
102
52
55
36
63
56
48
31
59
74
51
39
80
84
62
62
81
95
Net Profit
17
21
12
26
33
48
55
41
44
-20
96
106
51
66
120
160
109
132
196
197
128
454
276
260
151
285
258
218
110
140
166
115
85
167
162
137
65
204
244
EPS in ₹
1.31
1.66
0.98
2.09
2.61
3.77
4.35
3.28
3.52
-1.60
7.64
8.37
4.07
5.19
9.48
12.68
8.67
10.45
15.51
15.56
10.11
35.90
21.79
20.49
11.94
22.45
20.31
8.60
4.34
5.67
6.53
4.54
3.34
6.57
6.39
5.40
2.55
8.05
9.62
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
3,824
3,905
3,968
4,108
4,458
5,185
6,010
7,438
8,447
8,659
Fixed Assets
1,753
1,977
1,946
1,855
1,740
1,841
1,869
2,153
2,479
2,524
Current Assets
1,593
1,600
1,712
1,907
2,286
2,712
3,278
4,224
4,875
3,510
Capital Work in Progress
267
129
95
73
66
84
182
297
123
175
Investments
0
97
212
216
322
649
868
1,339
1,057
2,654
Other Assets
1,804
1,702
1,716
1,964
2,329
2,611
3,092
3,650
4,789
3,306
Total Liabilities
1,590
1,622
1,493
1,413
1,321
1,507
1,257
1,963
2,570
2,311
Current Liabilities
894
960
946
993
1,014
1,242
1,066
1,354
1,678
1,520
Non Current Liabilities
697
662
546
420
307
265
192
609
892
790
Total Equity
2,233
2,283
2,475
2,695
3,137
3,678
4,753
5,476
5,877
6,349
Reserve & Surplus
2,208
2,258
2,450
2,670
3,111
3,652
4,727
5,450
5,852
6,323
Share Capital
25
25
25
25
25
25
25
25
25
25
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
25
68
-31
74
150
-76
229
446
559
-990
Investing Activities
-686
-214
-146
-119
-123
-499
-560
-812
-710
-1,355
Operating Activities
455
696
271
324
496
561
1,096
832
762
831
Financing Activities
255
-414
-156
-130
-223
-139
-307
426
506
-465
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.29 %
46.30 %
46.30 %
46.30 %
FIIs
17.47 %
17.81 %
18.46 %
12.34 %
11.02 %
10.61 %
10.55 %
10.44 %
10.57 %
10.05 %
9.85 %
10.27 %
10.50 %
10.85 %
10.83 %
DIIs
24.82 %
25.11 %
25.24 %
30.02 %
32.70 %
33.50 %
33.81 %
34.05 %
34.08 %
35.19 %
35.05 %
34.52 %
34.38 %
33.79 %
34.23 %
Government
0.28 %
0.22 %
0.22 %
0.24 %
0.24 %
0.24 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.14 %
10.57 %
9.80 %
11.11 %
9.75 %
9.37 %
9.35 %
9.22 %
9.07 %
8.48 %
8.81 %
8.92 %
8.82 %
9.06 %
8.64 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,763.60 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,455.95 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,535.60 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,194.30 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
941.50 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,036.60 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,221.45 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,549.90 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,461.50 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,566.95 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
52.38
ATR(14)
Less Volatile
51.43
STOCH(9,6)
Neutral
40.33
STOCH RSI(14)
Neutral
55.27
MACD(12,26)
Bearish
-6.46
ADX(14)
Weak Trend
17.13
UO(9)
Bearish
45.40
ROC(12)
Uptrend And Accelerating
0.79
WillR(14)
Neutral
-33.81
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.